-conazole
An azole antifungal: blocks the fungal enzyme that makes ergosterol for the cell membrane.
- Drugs ending in -conazole: 25
- Approved somewhere: 14
- With a US drug page: 12
- Stem
- -conazole
- Class
- Azole antifungals taken by mouth or vein, related to miconazole
Approved and clinical-stage drugs in ChEMBL whose names ending in -conazole, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Efinaconazole | Approved | Lanosterol 14-alpha demethylase | Lanosterol 14-alpha demethylase inhibitor |
| Fluconazole | Approved | ERG11 | Cytochrome P450 51 inhibitor |
| Itraconazole | Approved | ERG11 | Cytochrome P450 51 inhibitor |
| Ketoconazole | Approved | ERG11 | Cytochrome P450 51 inhibitor |
| Levoketoconazole | Approved | CYP11B1, CYP11B2, CYP17A1, CYP11A1 | Cytochrome P450 11B1 inhibitor |
| Luliconazole | Approved | ERG11 | Cytochrome P450 51 inhibitor |
| Miconazole | Approved | ERG11 | Cytochrome P450 51 inhibitor |
| Oteseconazole | Approved | ERG11 | Lanosterol 14-alpha demethylase inhibitor |
| Posaconazole | Approved | ERG11 | Cytochrome P450 51 inhibitor |
| Voriconazole | Approved | ERG11 | Cytochrome P450 51 inhibitor |
| Terconazole | Phase 3 | ERG11 | Cytochrome P450 51 inhibitor |
| Tioconazole | — | ERG11 | Cytochrome P450 51 inhibitor |
| Econazole | Approved | ERG11 | Cytochrome P450 51 inhibitor |
| Oxiconazole | Approved | ERG11 | Cytochrome P450 51 inhibitor |
| Sertaconazole | Approved | ERG11 | Cytochrome P450 51 inhibitor |
| Sulconazole | Approved | ERG11 | Cytochrome P450 51 inhibitor |
| Butoconazole | Phase 3 | ERG11 | Cytochrome P450 51 inhibitor |
| Dapaconazole | Phase 3 | — | — |
| Isavuconazole | Phase 3 | — | — |
| Albaconazole | Phase 2 | ERG11 | Lanosterol 14-alpha demethylase inhibitor |
| Arasertaconazole | Phase 2 | — | — |
| Fosravuconazole | Phase 2 | ERG11 | Cytochrome P450 51 inhibitor |
| Opelconazole | Phase 2 | — | — |
| Etaconazole | Phase 1 | — | — |
| Ravuconazole | Phase 1 | ERG11 | Cytochrome P450 51 inhibitor |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO